Biological drugs, or biologics, are innovative therapies for people with debilitating and life-threatening diseases; but these drugs are expensive. In this Q&A, AIR’s Thiyagu Rajakannan, senior researcher and lead for Drug Coverage and Payment Practice in the Health Division at AIR, explains how lower-cost versions of these drugs and promising ...